Posts Tagged ‘stemcellworx’

Stem Cells Help Boy With Cerebral Palsy To Walk

Friday, November 9th, 2012

EASTERN SHORE, Md. (WJZ)

The miracle of stem cells changes the life of a little boy from the Eastern Shore.

Adam May has the amazing story of a mother and the choice she made moments after her son was born.

Xander McKinley was a beautiful baby–but challenging.  The newborn didn’t eat or sleep well, and by two-years-old, he couldn’t walk or even crawl.

“Something just wasn’t right,” said Xander’s mother, Jennifer McKinley.

Jennifer McKinley got the news every parent fears. Xander had cerebral palsy – a brain condition that slows motor functions.

Jennifer explains: “We thought he wasn’t going to be able to walk. It was heart-wrenching, that we knew this was permanent.”

Turns out, it wasn’t permanent. That young boy frustrated by immobility can now stand on his own, and even take a few steps after a groundbreaking experimental stem cell transfusion.   Click the video.

Video – Xander Is Now Walking

Xander can now practically run across his Eastern Shore farm with his walker. He can even climb the stairs on his swing-set for the first time in his life.

All of this possible because Xander’s parents decided to store blood from his umbilical cord when he was born. They never imagined that years later their decision would change their son’s life.

Doctor’s believe this amazing transformation came from stem cells extracted from Xander’s own umbilical cord. After undergoing the transfusion, those stem cells repaired Xander’s body.

“What we’re fighting most of all is ignorance. We have to raise awareness,” said Dr. Frances Verter, who runs the Parents Guide to Cord Blood Foundation.

Storing cord blood is an option many parents are not aware of, but some think it should become routine in the unlikely chance it’s needed.

“The goal is for everyone to save the cord blood,” he said.

Researchers are also studying how cord blood could someday treat brain injuries, diabetes, heart conditions, cancers and hearing loss.

Very few parents of newborns actually sign up for a cord blood registry.

Jennifer: “I would highly recommend it because you never know what’s going to happen.”

Xander’s now in physical therapy to activate muscles that have never been used, and his outlook is promising.

Cord blood can be stored privately, or donated to a public bank.

As published by:  CBSBaltimore

Stem Cell Treatments Offer Huge Protential

Saturday, September 15th, 2012

Blogged by Stem Cell Worx. As reported in the Irish Medical Times.

Scientists at NUI Galway are investigating how adult stem cells might be used to develop new treatments for vascular disease, osteoarthritis and lung injury.

Stem cells hold great promise as an alternative to drugs and surgical procedures for treating a wide range of medical conditions including heart disease, arterial disease of the limbs, diabetes complications, arthritis and other inflammatory conditions, Prof Frank Barry said.

The University has become a leading centre of translational research in adult stem cells involving its National Centre for Biomedical Engineering Science (NCBES) and REMEDI.

A new Irish company Orbsen Therapeutics is developing proprietary technologies designed to isolate stem cells. Prof Barry is a Director of Orbsen Therapeutics. The NUI Galway spin-out is targeting the expanding regenerative medicine market. The treatment potential of stem cells is linked to their natural capacity to dampen inflammation and promote healing, repair and regeneration of damaged tissues.

According to Prof Barry: “Ireland has a strong research base in adult stem cell therapy and has the capacity for advanced stem cell bio-processing. There is huge potential in this market and we anticipate that there will be extraordinary growth over the next five-to-10 years. There are currently over 400 regenerative medicine products on the market with many more in development.” Orbsen Therapeutics has developed a clear pipeline of clinical indications which it hopes — using proprietary technologies — to bring through to clinical trial over the coming years. These include osteoarthritis, acute lung injury syndrome, diabetic foot ulcer, critical limb ischaemia and others. “Combining the utility, novelty and the value of its technologies, Orbsen is well-placed to take advantage of the many opportunities in this fast-moving and important emerging market”, said Brian Molloy, CEO of Orbsen Theraepeutics.